HK1175786A1 - Synthetic lta mimetics and use thereof as vaccine component for therapy and/or prophylaxis against gram-positive infections lta / - Google Patents

Synthetic lta mimetics and use thereof as vaccine component for therapy and/or prophylaxis against gram-positive infections lta /

Info

Publication number
HK1175786A1
HK1175786A1 HK13103062.2A HK13103062A HK1175786A1 HK 1175786 A1 HK1175786 A1 HK 1175786A1 HK 13103062 A HK13103062 A HK 13103062A HK 1175786 A1 HK1175786 A1 HK 1175786A1
Authority
HK
Hong Kong
Prior art keywords
lta
mimetics
therapy
against gram
synthetic
Prior art date
Application number
HK13103062.2A
Other languages
English (en)
Chinese (zh)
Inventor
Johannes Huebner
Andrea Kropec-Huebner
Marel Gijsbert Arie Van Der
Wouter Frederik Johan Hogendorf
Jeroen Dirk Cornelis Code
Original Assignee
Universittsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universittsklinikum Freiburg filed Critical Universittsklinikum Freiburg
Publication of HK1175786A1 publication Critical patent/HK1175786A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/11—Esters of phosphoric acids with hydroxyalkyl compounds without further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK13103062.2A 2011-03-11 2013-03-12 Synthetic lta mimetics and use thereof as vaccine component for therapy and/or prophylaxis against gram-positive infections lta / HK1175786A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20110157947 EP2500349B1 (de) 2011-03-11 2011-03-11 Synthetische LTA-Mimetika und deren Verwendung als Impfstoffbestandteil zur Therapie und/oder Prophylaxe gegen grampositive Infektionen

Publications (1)

Publication Number Publication Date
HK1175786A1 true HK1175786A1 (en) 2013-07-12

Family

ID=43828266

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13103062.2A HK1175786A1 (en) 2011-03-11 2013-03-12 Synthetic lta mimetics and use thereof as vaccine component for therapy and/or prophylaxis against gram-positive infections lta /

Country Status (7)

Country Link
US (1) US9290531B2 (de)
EP (1) EP2500349B1 (de)
JP (1) JP6154751B2 (de)
CA (1) CA2829126A1 (de)
ES (1) ES2544808T3 (de)
HK (1) HK1175786A1 (de)
WO (1) WO2012119846A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2780351B1 (de) * 2011-11-18 2019-12-18 National Research Council of Canada (NRC) Clostridium difficile-lipoteichonsäure und verwendungen davon
WO2018013999A1 (en) 2016-07-15 2018-01-18 Am Chemicals Llc Non-nucleosidic solid supports and phosphoramidite building blocks for oligonucleotide synthesis
KR101950881B1 (ko) * 2017-08-10 2019-02-22 서울대학교산학협력단 리포테이코익산(Lipoteichoic acid(LTA))을 함유하는 피부 재생 및 창상 치유용 약학 조성물
MX2020002557A (es) 2017-09-07 2020-07-13 Merck Sharp & Dohme Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2208780C (en) * 1995-01-30 2010-03-30 Peter Truog Antitumor and anticholesterol preparations comprising lipoteichoic acid lta-t of streptococcus sp dsm 8747
AUPQ137699A0 (en) 1999-07-02 1999-07-22 University Of New England, The Control of acidosis
EP1474432A1 (de) * 2002-02-04 2004-11-10 Biomira Inc. Immunstimulierende, kovalent lipid-modifizierte oligonukleotide

Also Published As

Publication number Publication date
EP2500349A1 (de) 2012-09-19
ES2544808T3 (es) 2015-09-04
US9290531B2 (en) 2016-03-22
WO2012119846A1 (en) 2012-09-13
JP6154751B2 (ja) 2017-06-28
CA2829126A1 (en) 2012-09-13
JP2014507450A (ja) 2014-03-27
US20140050741A1 (en) 2014-02-20
EP2500349B1 (de) 2015-05-06

Similar Documents

Publication Publication Date Title
HK1207002A1 (en) Compositions comprising cocktails of antibacterial phages and uses thereof for the treatment of bacterial infections
HK1225649A1 (zh) 用於治療細菌性感染的化合物和方法
IL242770B (en) A therapeutic combination that includes oxazolidinone-quinolones for use in the treatment of bacterial infections
HK1210018A1 (en) Tailored liposomes for the treatment of bacterial infections
HK1218293A1 (zh) 治療細菌感染的化合物和方法
GB201212588D0 (en) Colicins for treating bacterial infections
EP2802353A4 (de) Zusammensetzungen und verfahren zur behandlung von virusinfektionen
EP2869821A4 (de) Zusammensetzungen und verfahren zur behandlung und hemmung von virusinfektionen
IL233486A0 (en) Synthetic peptides for the treatment of bacterial infections
ZA201503474B (en) Compositions and methods for treating bacterial infections
EP2969003A4 (de) Verfahren und zusammensetzungen für bakterieninfektionen
EP2844258A4 (de) Verfahren und zusammensetzungen zur behandlung von bakteriellen infektionen
HK1175786A1 (en) Synthetic lta mimetics and use thereof as vaccine component for therapy and/or prophylaxis against gram-positive infections lta /
EP2916653A4 (de) Antibiotische verfahren und zusammensetzungen für bakterieninfektionen
HK1212619A1 (zh) 眼部感染的治療或預防方法
IL234777A (en) Erythuran or its salts suitable for pharmacological use in the treatment of Orthomix virus infections
ZA201308025B (en) The use of secnidazole in treating dental infections
EP2838903A4 (de) Verfahren und zusammensetzungen zur behandlung von virusinfektionen
EP2854777A4 (de) Kombinierte therapie und prophylaxe für infektionen des genitaltrakts
SI2771016T1 (sl) Primicin in njegove komponente za uporabo pri zdravljenju ali preventivi okužb povzročenimi s specifičnimi patogeni
EP2772248A4 (de) Pharmazeutische zusammensetzung und kit zur behandlung von bakteriellen infektionen
EP2665738A4 (de) Verbindungen zur verwendung bei der behandlung bakterieller infektionen
GB201223371D0 (en) Novel mucinase for use in therapy or prophylaxis
GB201208770D0 (en) Compounds for use in the treatment of adenovirus infections
GB201314623D0 (en) Novel mucinase for use in therapy or prophylaxis

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220313